Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$0.99 - $1.61 $203,043 - $330,201
-205,094 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$2.88 - $4.81 $590,670 - $986,502
205,094 New
205,094 $767,000

Others Institutions Holding VYNT

About Vyant Bio, Inc.


  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track Blankinship & Foster, LLC Portfolio

Follow Blankinship & Foster, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blankinship & Foster, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blankinship & Foster, LLC with notifications on news.